Add to ORKGDermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by proximal muscle weakness associated with a distinct cutaneous eruption. The association of DM with malignancy has been extensively described in the literature. Patients with DM that also have transcriptional intermediary factor
Dermatomyositis (DM) is a rare treatable muscle disorder with a reported favorable outcome in most p...
<p>Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired systemic diseases ...
The association between malignancy and autoimmune myositis has been largely described and confirmed ...
Introduction: Myositis specific autoantibodies are associated with unique clinical subsets and are u...
We retrospectively analyzed the clinical and laboratory data of patients diagnosed with anti-transcr...
Introduction: Myositis specific autoantibodies are associated with unique clinical subsets and are u...
Anti-transcriptional intermediary factor-1γ (TIF-1γ) autoantibody may be associated with cancer in a...
Small cell neuroendocrine carcinoma is rare among urinary bladder cancer types, and to date, there a...
Dermatomyositis (DM) is an uncommon inflammatory myopathy of unknown aetiology characterized by pain...
SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients wit...
This study aims to characterize myositis-specific antibodies in a well-defined cohort of patients wi...
Background: Dermatomyositis (DM) is the idiopathic inflammatory myopathy most associated to malignan...
Introduction: Myositis specific autoantibodies are associated with unique clinical subsets and are u...
Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by the presence of skin le...
IF 2.969International audienceAnti-Mi2 are dermatomyositis-specific autoantibodies (Aabs) that have ...
Dermatomyositis (DM) is a rare treatable muscle disorder with a reported favorable outcome in most p...
<p>Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired systemic diseases ...
The association between malignancy and autoimmune myositis has been largely described and confirmed ...
Introduction: Myositis specific autoantibodies are associated with unique clinical subsets and are u...
We retrospectively analyzed the clinical and laboratory data of patients diagnosed with anti-transcr...
Introduction: Myositis specific autoantibodies are associated with unique clinical subsets and are u...
Anti-transcriptional intermediary factor-1γ (TIF-1γ) autoantibody may be associated with cancer in a...
Small cell neuroendocrine carcinoma is rare among urinary bladder cancer types, and to date, there a...
Dermatomyositis (DM) is an uncommon inflammatory myopathy of unknown aetiology characterized by pain...
SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients wit...
This study aims to characterize myositis-specific antibodies in a well-defined cohort of patients wi...
Background: Dermatomyositis (DM) is the idiopathic inflammatory myopathy most associated to malignan...
Introduction: Myositis specific autoantibodies are associated with unique clinical subsets and are u...
Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by the presence of skin le...
IF 2.969International audienceAnti-Mi2 are dermatomyositis-specific autoantibodies (Aabs) that have ...
Dermatomyositis (DM) is a rare treatable muscle disorder with a reported favorable outcome in most p...
<p>Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired systemic diseases ...
The association between malignancy and autoimmune myositis has been largely described and confirmed ...